Metabolite patterns of patients with peripheral arterial disease in response to exercise
暂无分享,去创建一个
O. Fiehn | S. Damrauer | E. Mohler | J. Newman | R. Judy | Jonni S. Moore | K. Borkowski | N. Tsao | Tiffany R. Bellomo | G. Shakt | Hillary A. Johnston-Cox | Gabrielle Shakt | Sarah J. Ractcliffe | Kamil Borkowski | Tiffany R. Bellomo
[1] Eoin Fahy,et al. RefMet: a reference nomenclature for metabolomics , 2020, Nature Methods.
[2] R. Tibshirani,et al. Lasso and Elastic-Net Regularized Generalized Linear Models [R package glmnet version 4.0-2] , 2020 .
[3] P. Britz‐McKibbin,et al. Serum Metabolic Signatures of Chronic Limb-Threatening Ischemia in Patients with Peripheral Artery Disease , 2020, Journal of clinical medicine.
[4] K. Maemura,et al. The Relationship between Circulating Polyunsaturated Fatty Acid Levels and Exercise Responses of Patients with Non-ischemic Heart Failure , 2019, Internal medicine.
[5] O. Fiehn,et al. Exercise plasma metabolomics and xenometabolomics in obese, sedentary, insulin-resistant women: impact of a fitness and weight loss intervention. , 2019, American journal of physiology. Endocrinology and metabolism.
[6] J. Nelson,et al. The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease , 2019, Postgraduate medicine.
[7] Ira Tabas,et al. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities , 2019, Nature Reviews Cardiology.
[8] M. Gibala,et al. Characterization of the Human Skeletal Muscle Metabolome for Elucidating the Mechanisms of Bicarbonate Ingestion on Strenuous Interval Exercise. , 2019, Analytical chemistry.
[9] Christopher J. Lambert,et al. Skeletal muscle interstitial fluid metabolomics at rest and associated with an exercise bout: application in rats and humans. , 2019, American journal of physiology. Endocrinology and metabolism.
[10] D. Barrett,et al. An Analysis of Endocannabinoid Concentrations and Mood Following Singing and Exercise in Healthy Volunteers , 2018, Front. Behav. Neurosci..
[11] E. Pennisi,et al. Lipid Myopathies , 2018, Journal of clinical medicine.
[12] G. Weiss,et al. Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases , 2018, International journal of molecular sciences.
[13] J. Newman,et al. Oral ibuprofen differentially affects plasma and sweat lipid mediator profiles in healthy adult males. , 2018, Prostaglandins & other lipid mediators.
[14] E. A. Hafez,et al. Synopsis of arachidonic acid metabolism: A review , 2018, Journal of advanced research.
[15] Andries T Marees,et al. A tutorial on conducting genome‐wide association studies: Quality control and statistical analysis , 2018, International journal of methods in psychiatric research.
[16] S. Machida,et al. Endurance exercise training and high-fat diet differentially affect composition of diacylglycerol molecular species in rat skeletal muscle , 2018, American journal of physiology. Regulatory, integrative and comparative physiology.
[17] E. Liepinsh,et al. Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues , 2017, Scientific Reports.
[18] Erin K. Englund,et al. Effects of exercise training on calf muscle oxygen extraction and blood flow in patients with peripheral artery disease. , 2017, Journal of applied physiology.
[19] L. V. van Loon,et al. α‐Linolenic acid and exercise training independently, and additively, decrease blood pressure and prevent diastolic dysfunction in obese Zucker rats , 2017, The Journal of physiology.
[20] M. Maccarrone. Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years , 2017, Front. Mol. Neurosci..
[21] M. Maiuri,et al. Metabolic effects of fasting on human and mouse blood in vivo , 2017, Autophagy.
[22] L. Fleisher,et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary , 2016, Circulation.
[23] K. Calligaro,et al. Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. , 2016, Journal of vascular surgery.
[24] R. Murphy,et al. The discovery and early structural studies of arachidonic acid , 2016, Journal of Lipid Research.
[25] A. Dirican,et al. Increased IL18 mRNA levels in peripheral artery disease and its association with triglyceride and LDL cholesterol levels: a pilot study , 2016, Heart and Vessels.
[26] M. Monreal,et al. Quality assessment of peripheral artery disease clinical guidelines. , 2016, Journal of vascular surgery.
[27] E. Armstrong,et al. Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options. , 2016, Journal of the American College of Cardiology.
[28] R. D. de Bie,et al. Patient Characteristics and Comorbidities Influence Walking Distances in Symptomatic Peripheral Arterial Disease: A Large One-Year Physiotherapy Cohort Study , 2016, PloS one.
[29] Cheng Li,et al. Pulse sequence programming in a dynamic visual environment: SequenceTree , 2016, Magnetic resonance in medicine.
[30] W. H. Hoffmann,et al. Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical Trial. , 2015, JAMA.
[31] J. Kals,et al. Metabolomic signature of arterial stiffness in male patients with peripheral arterial disease , 2015, Hypertension Research.
[32] M. McDermott. Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. , 2015, Circulation research.
[33] Erin K. Englund,et al. Multiparametric assessment of vascular function in peripheral artery disease: dynamic measurement of skeletal muscle perfusion, blood-oxygen-level dependent signal, and venous oxygen saturation. , 2015, Circulation. Cardiovascular imaging.
[34] J. Massaro,et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. , 2015, Journal of the American College of Cardiology.
[35] N. Smart,et al. Exercise Training for Management of Peripheral Arterial Disease: A Systematic Review and Meta-Analysis , 2015, Sports Medicine.
[36] D. Cook,et al. Mechanisms of exercise-induced hypoalgesia. , 2014, The journal of pain : official journal of the American Pain Society.
[37] D. Nomura,et al. Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. , 2014, Chemical Society reviews.
[38] Jiang He,et al. BMI and waist circumference are associated with impaired glucose metabolism and type 2 diabetes in normal weight Chinese adults. , 2014, Journal of diabetes and its complications.
[39] T. Harkany,et al. The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels , 2014, Proceedings of the National Academy of Sciences.
[40] Taro Kimura,et al. Hydroxylamine enhances glucose uptake in C2C12 skeletal muscle cells through the activation of insulin receptor substrate 1. , 2014, Biochemical and biophysical research communications.
[41] Igor Rudan,et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis , 2013, The Lancet.
[42] Benjamin D. Kuiper,et al. Hydroxylamine acutely activates glucose uptake in L929 fibroblast cells. , 2013, Biochimie.
[43] D. Raichlen,et al. Exercise-induced endocannabinoid signaling is modulated by intensity , 2013, European Journal of Applied Physiology.
[44] Patrice D Cani,et al. Chronic Endocannabinoid System Stimulation Induces Muscle Macrophage and Lipid Accumulation in Type 2 Diabetic Mice Independently of Metabolic Endotoxaemia , 2013, PloS one.
[45] F. Gamelin,et al. The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[46] F. Gamelin,et al. Intense exercise increases circulating endocannabinoid and BDNF levels in humans—Possible implications for reward and depression , 2012, Psychoneuroendocrinology.
[47] R. Rodríguez‐Gutiérrez,et al. Impact of an exercise program on acylcarnitines in obesity: a prospective controlled study , 2012, Journal of the International Society of Sports Nutrition.
[48] Xiaoping Wang,et al. Multiple roles of dihomo-γ-linolenic acid against proliferation diseases , 2012, Lipids in Health and Disease.
[49] P. Pacher,et al. The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications. , 2012, The American journal of pathology.
[50] J. Ehrman,et al. Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery Disease: Six-Month Outcomes From the Claudication Exercise Versus Endoluminal Revascularization (CLEVER) Study , 2012, Circulation.
[51] I. Chetter,et al. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease , 2012, The British journal of surgery.
[52] Lu Tian,et al. A Perturbation Method for Inference on Regularized Regression Estimates , 2011, Journal of the American Statistical Association.
[53] D. Reeds,et al. Omega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperinsulinaemia-hyperaminoacidaemia in healthy young and middle-aged men and women. , 2011, Clinical science.
[54] S. Lahiri,et al. Bootstrapping Lasso Estimators , 2011 .
[55] Akshay S. Desai,et al. Impaired Skeletal Muscle Glucose Uptake by [18F]Fluorodeoxyglucose–Positron Emission Tomography in Patients With Peripheral Artery Disease and Intermittent Claudication , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[56] S. Kuang,et al. Peripheral endocannabinoids regulate skeletal muscle development and maintenance , 2010 .
[57] M. Gibala. Carbohydrate availability and training adaptation. , 2010, Exercise and sport sciences reviews.
[58] J. Ehrman,et al. Design of the multicenter standardized supervised exercise training intervention for the ‘CLaudication: Exercise Vs Endoluminal Revascularization (CLEVER) study’ , 2009, Vascular medicine.
[59] Bruce D. Hammock,et al. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases , 2009, Nature Reviews Drug Discovery.
[60] John V. White,et al. Invasive treatment of claudication is indicated for patients unable to adequately ambulate during cardiac rehabilitation. , 2009, Journal of vascular surgery.
[61] S. Cornish,et al. Alpha-linolenic acid supplementation and resistance training in older adults. , 2009, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[62] Sidney C. Smith,et al. Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases. , 2008, Circulation.
[63] S. Thompson,et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease , 2008 .
[64] L. Sidossis,et al. Acute exercise-induced changes in basal VLDL-triglyceride kinetics leading to hypotriglyceridemia manifest more readily after resistance than endurance exercise. , 2008, Journal of applied physiology.
[65] Andreas Christmann,et al. Support vector machines , 2008, Data Mining and Knowledge Discovery Handbook.
[66] T. Hothorn,et al. Simultaneous Inference in General Parametric Models , 2008, Biometrical journal. Biometrische Zeitschrift.
[67] G. Wittert,et al. The expression of receptors for endocannabinoids in human and rodent skeletal muscle. , 2007, Biochemical and biophysical research communications.
[68] J. Horowitz,et al. Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. , 2007, The Journal of clinical investigation.
[69] G. Wittert,et al. Effects of cannabinoid receptors on skeletal muscle oxidative pathways , 2007, Molecular and Cellular Endocrinology.
[70] T. Barstow,et al. Skeletal muscle StO2 kinetics are slowed during low work rate calf exercise in peripheral arterial disease , 2007, European Journal of Applied Physiology.
[71] A. Prasad,et al. Newer Classification and Regression Tree Techniques: Bagging and Random Forests for Ecological Prediction , 2006, Ecosystems.
[72] Lu Tian,et al. Physical Performance in Peripheral Arterial Disease: A Slower Rate of Decline in Patients Who Walk More , 2006, Annals of Internal Medicine.
[73] S. Goodman,et al. Management of risk in peripheral artery disease: recent therapeutic advances. , 2005, American heart journal.
[74] H. Zou,et al. Regularization and variable selection via the elastic net , 2005 .
[75] M. Stock,et al. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice , 2005, International Journal of Obesity.
[76] A. Dietrich,et al. Endocannabinoids and exercise , 2004, British Journal of Sports Medicine.
[77] W. Hiatt,et al. Impaired muscle oxygen use at onset of exercise in peripheral arterial disease. , 2004, Journal of vascular surgery.
[78] Bernhard Schölkopf,et al. A tutorial on support vector regression , 2004, Stat. Comput..
[79] J. Regensteiner,et al. Exercise training for claudication. , 2002, The New England journal of medicine.
[80] P. Neufer,et al. Transcriptional activation of the IL‐6 gene in human contracting skeletal muscle: influence of muscle glycogen content , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[81] M. Sullivan,et al. Treatment efficacy of intermittent claudication by surgical intervention, supervised physical exercise training compared to no treatment in unselected randomised patients I: one year results of functional and physiological improvements. , 2001, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[82] W. Hiatt,et al. Medical treatment of peripheral arterial disease and claudication. , 2001, The New England journal of medicine.
[83] M. Corretti,et al. Effects of exercise rehabilitation on endothelial reactivity in older patients with peripheral arterial disease. , 2001, The American journal of cardiology.
[84] W. Hiatt,et al. Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease , 2000, Vascular medicine.
[85] J. Regensteiner,et al. Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. , 1996, Journal of applied physiology.
[86] P. Morris,et al. Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. , 1996, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[87] D. Gibson,et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.
[88] J. Regensteiner,et al. Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease. , 1992, Journal of applied physiology.
[89] L. Smith,et al. Acute inflammation: the underlying mechanism in delayed onset muscle soreness? , 1991, Medicine and science in sports and exercise.
[90] J. Skinner,et al. Progressive vs single-stage treadmill tests for evaluation of claudication. , 1991, Medicine and science in sports and exercise.
[91] P. Thompson,et al. What do muscles have to do with lipoproteins? , 1990, Circulation.
[92] P. Morris,et al. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. , 1990, European journal of vascular surgery.
[93] J. Regensteiner,et al. Benefit of exercise conditioning for patients with peripheral arterial disease. , 1990, Circulation.
[94] R. Volkmann,et al. Intermittent Claudication—Surgical Reconstruction or Physical Training?: A Prospective Randomized Trial of Treatment Efficiency , 1989, Annals of surgery.
[95] E. Ernst,et al. Intermittent claudication, exercise, and blood rheology. , 1987, Circulation.
[96] N. Lassen,et al. Effect of daily muscular exercise in patients with intermittent claudication. , 1966, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[97] M. Garg,et al. Arachidonic acid supplementation modulates blood and skeletal muscle lipid profile with no effect on basal inflammation in resistance exercise trained men. , 2018, Prostaglandins, leukotrienes, and essential fatty acids.
[98] I. Chetter,et al. A Review of the Potential Local Mechanisms by Which Exercise Improves Functional Outcomes in Intermittent Claudication. , 2016, Annals of vascular surgery.
[99] R. Florio,et al. The fatty acid amide hydrolase in lymphocytes from sedentary and active subjects. , 2014, Medicine and science in sports and exercise.
[100] I. Chetter,et al. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. , 2010, Annals of vascular surgery.
[101] F. Fezza,et al. Endocannabinoids in adipocytes during differentiation and their role in glucose uptake , 2006, Cellular and Molecular Life Sciences.
[102] W. Kraus,et al. Exercise-induced angiogenesis-related growth and transcription factors in skeletal muscle, and their modification in muscle pathology. , 2001, Frontiers in bioscience : a journal and virtual library.
[103] C. Shearman,et al. The evidence for exercise-induced inflammation in intermittent claudication: should we encourage patients to stop walking? , 1998, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.